BackIdeaya Biosciences Overview
Ideaya Biosciences Inc

Ideaya Biosciences Target Price

Where could IDYA trade next? Consensus target price: $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$37.59

Average Target Price

$57.0051.6% upside

4 analysts in the last 4 months

High: $63 | Low: $48

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09Guggenheim$5751.6% upsideOpen
2026-08-05Wedbush$6059.6% upsideOpen
2026-07-07Truist FinancialGregory Renza$6367.6% upsideOpen
2026-07-07RBC Capital$4827.7% upsideOpen
2026-04-14Wedbush$5854.3% upsideOpen
2026-04-14RBC Capital$5341% upsideOpen
2026-04-13Truist Financial$6572.9% upsideOpen
2026-02-18Wedbush$5238.3% upsideOpen
2026-01-21RBC Capital$4519.7% upsideOpen
2026-01-06Truist FinancialGregory Renza$6059.6% upsideOpen
2025-11-24Truist Financial$5957% upsideOpen
2025-10-21New Street$3020.2% downsideOpen
2025-10-21RBC Capital$419.1% upsideOpen
2025-09-17Guggenheim$5033% upsideOpen
2025-09-09RBC CapitalGregory Renza$381.1% upsideOpen
2025-09-08OppenheimerMatthew Biegler$364.2% downsideOpen
2025-09-04JMP Securitieslvan Tuerkcan$419.1% upsideOpen
2025-09-04Barclays$406.4% upsideOpen
2024-11-05Leerink PartnersAndrew Berens$2728.2% downsideOpen
2024-10-24UBSDavid Dai$5033% upsideOpen
2024-09-25Mizuho SecuritiesGraig Suvannavejh$5546.3% upsideOpen
2024-09-23Goldman SachsCorinne Jenkins$4827.7% upsideOpen
2024-09-23Stifel NicolausBen Burnett$6675.6% upsideOpen
2024-09-23BTIGJustin Zelin$6264.9% upsideOpen
2024-09-10Stifel NicolausBen Burnett$6880.9% upsideOpen
2024-08-27CitigroupYigal Nochomovitz$5854.3% upsideOpen
2024-08-07OppenheimerMatthew Biegler$5341% upsideOpen
2024-07-10RBC CapitalGregory Renza$6162.3% upsideOpen
2024-07-08Mizuho SecuritiesGraig Suvannavejh$5033% upsideOpen
2024-06-03Stifel NicolausBen Burnett$6367.6% upsideOpen
2022-12-28Capital One Financial$2922.9% downsideOpen
2022-09-13Guggenheim$3214.9% downsideOpen
2022-08-18Oppenheimer$2046.8% downsideOpen
2022-08-16Robert W. Baird$1852.1% downsideOpen

Ideaya Biosciences (IDYA) FAQ

The latest target price for IDYA is $57. Investors often review this figure alongside Ideaya Biosciences's historical trend and sector peers before judging valuation or financial health.

Ideaya Biosciences trades near $37.59 while the consensus target sits at $57 (51.6% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting IDYA's target price ($57), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ideaya Biosciences's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.